A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Part of paid clinical trials in Oakland, California.
- Sponsor
- Ricoh USA, Inc.
- Study ID
- NCT06387485
- Status
- Recruiting
Conditions
- Chondrosarcoma
- Fibrosarcoma
- Fibrous Histiocytoma
- Osteosarcoma
- Sarcoma, Ewing
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 3D Printed Anatomic Model — DEVICEPatient-specific 3D printed anatomic model for pre-surgical planning
- CT/MRI — DIAGNOSTIC_TESTStandard imaging type for bony tumors
Study Details
This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across up to 5 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging. Primary endpoint: Operative time of surgical procedure. Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins. Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.
Key Dates
- Start date
- Mar 1, 2024
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Active Comparator: Standard ImagingParticipants in this arm will undergo tumor excision with prior planning utilizing only Imaging (CT or MRI) without development of a 3D printed model
- Experimental: 3D Printed Anatomic ModelParticipants in this arm will have tumors excised with prior planning utilizing 3D printed models and Imaging (CT or MRI).
Primary Outcome Measure
Operative time [ Time Frame: Incision to closure ]
Central Contacts
- Alexandra Gormley, PhD484-501-0588
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kaiser Permanente Oakland Medical Center | Oakland | California | 94611 | |
| William Beaumont University Hospital | Royal Oak | Michigan | 48073 | |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43212 |
Find similar trials in Oakland, CA
Related Studies
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruiting · Children's Oncology Group · Birmingham, Alabama
- Pediatric PET/MR Image RegistryRecruiting · Stanford University · Palo Alto, California
- Losartan + Sunitinib in Treatment of OsteosarcomaPHASE1 · Recruiting · University of Colorado, Denver · Los Angeles, California
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPHASE1 · Recruiting · BioEclipse Therapeutics · Scottsdale, Arizona